In an animal study, Krebs et al. reported that a mutation in the MED30 gene results in lethal cardiomyopathy in the mouse heart, indicating a potential role of MED30 in human CVD-related metabolic disorders [43]. The gene discussed is MED30; the disease is metabolic disease.